Case Report

Hemorrhagic Tamponade Due to Cardiac Angiosarcoma

Authors: Estelle Vautrin, MD, Gilles Barone-Rochette, MD, Frederic Thony, MD, Sylvie Lantuejoul, MD, PhD, Daniel H.P. Towie, MD, Vincent Bach, MD, Jean-Philippe Baguet, MD, PhD

Abstract

Prognosis of angiosarcoma, the most common primary malignant cardiac tumor, is very poor. An early detection and treatment may extend survival beyond one year. Newer imaging modalities, including magnetic resonance imaging (MRI), play an important role in the evaluation of cardiac masses. The case of a man admitted to the emergency room for a cardiac tamponade is reported. Thoracic computed tomography and MRI diagnosed a pericardial tumor, for which surgical biopsy revealed an angiosarcoma. Chemotherapy was started, and the patient survived for 28 months. Etiologies of hemorrhagic tamponades are discussed, as well as treatment of cardiac angiosarcoma.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Atar S, Chiu J, Forrester JS, et al. Bloody pericardial effusion in patients with cardiac tamponade: is the cause cancerous, tuberculous, or iatrogenic in the 1990s? Chest 1999;116:1564–1569.
 
2. Colombo A, Olson HG, Egan J, et al. Etiology and prognostic implications of a large pericardial effusion in men. Clin Cardiol 1988;11:389–394.
 
3. Sagristà-Sauleda J, Mercé J, Permanyer-Miralada G, et al. Clinical clues to the causes of large pericardial effusions. Am J Med 2000;109:95–101.
 
4. Soler-Soler J, Sagristà-Salueda J, Permanyer-Miralda G. Management of pericardial effusion. Heart 2001;86:235–240.
 
5. Muir KW, Rodger JC. Cardiac tamponade as the initial presentation of malignancy: is it as rare as previously supposed? Postgrad Med J 1994;70:703–707.
 
6. Oliver Navarrete C, Marín Ortuño F, Pineda Rocamora J, et al. Should we try to determine the specific cause of cardiac tamponade? [in Spanish] Rev Esp Cardiol 2002;55:493–498.
 
7. Silverman NA. Primary cardiac tumor. Ann Surg 1980;191:127–138.
 
8. Oshima K, Ohtaki A, Kano M, et al. Primary cardiac angiosarcoma associated with cardiac tamponade: case report. Jpn Circ J 1999;63:822–824.
 
9. Calderón M, Galván J, Negri V, et al. Right ventricular bypass for palliation of cardiac sarcoma.Tex Heart Inst J 1996;23:178–179.
 
10. Ragland MM, Tak T. The role of echocardiography in diagnosing space-occupying lesions of the heart. Clin Med Res 2006;4:22–32.
 
11. Holtan SG, Allen RD, Henkel DM, et al. Angiosarcoma of the pericardium presenting as hemorrhagic pleuropericarditis, cardiac tamponade, and thromboembolic phenomena. Int J Cardiol 2006;115:e8–e9.
 
12. Cheong B, Huber S, Reul R, et al. Cardiovascular magnetic resonance imaging of sarcoma invading the left atrium and pericardium. Tex Heart Inst J 2005;32:608–609.
 
13. Herrmann MA, Shankerman RA, Edwards WD, et al. Primary cardiac angiosarcoma: a clinicopathologic study of six cases. J Thorac Cardiovasc Surg 1992;103:655–664.
 
14. Uberfuhr P, Meiser B, Fuchs A, et al. Heart transplantation: an approach to treating primary cardiac sarcoma? J Heart Lung Transplant 2002;21:1135–1139.